title: [Impact of integrated asthma treatment on the patients' quality of life].
abstract: BACKGROUND
  Patient's perception about the effect of disease's manifestations on daily activities is called health-related quality of life, and it is used to evaluate the individual response to treatment. At present, there are some questionnaires designed to evaluate it.
  
  
  OBJECTIVE
  To evaluate the effect of integral treatment dosage on quality of life in asthmatic adults.
  
  
  METHODS
  A prospective, longitudinal and experimental study was made. We included male and female adult patients, with allergic asthma. A standardized questionnaire of quality of life was applied to all of them in every visit, for eight times. The integral treatment was based on Global Initiative for Asthma judgments.
  
  
  RESULTS
  Ten patients were included, 70% of them were women. The media age was 37.4 +/- 15.73 years old. The asthma was diagnosed as intermittent in 10% cases, mild persistent in 20%, moderate persistent in 20% and severe persistent in 50% patients. The group of age most frequently affected was that of 20 to 30 years old. The media index of quality of life was 2.43 +/- 0.91 at the first visit and it was 5.73 +/- 1.11 at eighth visit. It was found a significant difference.
  
  
  CONCLUSIONS
  Integral treatment improves quality of life in asthmatic adults.
authors.affiliation: Servicio de alergia e inmunología clínica, Hospital Universitario de Puebla, Benemérita Universidad Autónoma de Puebla. asalazar@mail.medinet.net.mx
authors.forename: Alfredo Ariel
authors.initials: AA
authors.lastname: Salazar Aguilar
authors.forename: Aída Inés
authors.initials: AI
authors.lastname: López García
authors.forename: David
authors.initials: D
authors.lastname: Paz Martínez
authors.forename: José Arturo
authors.initials: JA
authors.lastname: Galindo García
authors.forename: Ricardo
authors.initials: R
authors.lastname: Martínez Olivares
authors.forename: Sergio
authors.initials: S
authors.lastname: Papaqui Tapia
mesh_terms: D000203:Activities of Daily Living; D000328:Adult; D000368:Aged; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000523:psychology / Q000628:therapy*; D019090:Case Management; D003131:Combined Modality Therapy; D003888:Desensitization, Immunologic; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009316:National Institutes of Health (U.S.); D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D011446:Prospective Studies; D011788:Quality of Life; D012129:Respiratory Function Tests; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D014481:United States; D014944:World Health Organization
chemical_list: D018927:Anti-Asthmatic Agents